Nuclera
Developer of a protein prototyping system designed to accelerate drug discovery workflows. The company's system helps construct design, expression, solubility characterization, and purification of tar...
Valuation
$154.5M
Market implied
Share Price
N/A
Total Raised
$154.1M
Last Round
Later Stage VC (Series C)
Jan 2026
Latest Funding Round
Later Stage VC (Series C)
Jan 13, 2026
$87M
raised
Leadership
Gordon McInroy Ph.D
Co-Founder, Chief Operating Officer & Board Member
Joseph Bertelsen
Chief Commercial Officer
Michael Chen Ph.D
Co-Founder, Chief Executive Officer & Board Member
Investors
+36 other investors